Home/Filings/4/0001161697-25-000084
4//SEC Filing

Del Carmen Jeffrey 4

Accession 0001161697-25-000084

CIK 0001369568other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:00 PM ET

Size

5.1 KB

Accession

0001161697-25-000084

Insider Transaction Report

Form 4
Period: 2025-03-03
Del Carmen Jeffrey
Chief Commercial Officer
Transactions
  • Sale

    Common stock, par value $0.001 per share

    2025-03-03$22.89/sh30,423$696,3820 total
Footnotes (1)
  • [F1]Shares were sold for personal reasons and not as a result of any disagreement with the Company.

Issuer

CATALYST PHARMACEUTICALS, INC.

CIK 0001369568

Entity typeother

Related Parties

1
  • filerCIK 0001816477

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:00 PM ET
Size
5.1 KB